· Periodic ReportMajor
Q3 operating profit KRW 11.9 billion, up 46.6% from a year earlier
PharmiCell sold KRW 37.0 billion in Q3 and earned KRW 11.9 billion from its main business, up 46.6% from a year earlier and down 9.8% from the prior quarter.
Pharmicell Co.,Ltd. Disclosures
005690 · KOSPI · Based on DART filings
Disclosures
1 total · 20 per page
Catch the next disclosure fast
Get app alerts for new disclosures from Pharmicell Co.,Ltd..